Translational Development Acquisition Corp. Ordinary Shares

Research Translational Development Acquisition Corp. Ordinary Shares (TDAC) on Bullrun: market cap USD 210.08M, P/E 42.9. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 210.08M; P/E is 42.9.

Peer valuation comparison

Latest P/E is 42.94x versus a Financial Services sector median of 13.04x (229.2% above).

Latest P/E is 42.94x versus a United States median of 24.66x (74.1% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 0USD 6.36M-USD 608.39Kn/a0.29USD 29.79KUSD 200.00K-USD 6.54M
FY2024USD 0-USD 71.01K-USD 851.45Kn/a-0.02USD 438.17KUSD 658.74K-USD 5.60M
FY2023USD 0-USD 485.55K-USD 204n/a-0.11USD 2.02KUSD 347.50K-USD 507.66K

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-11-13USD 210.08M42.9n/an/a
20252025-12-31USD 229.81M36.2n/an/a

About Translational Development Acquisition Corp. Ordinary Shares

Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.

Related stock research

Other Financial Services stocks

Frequently asked questions

What is Translational Development Acquisition Corp. Ordinary Shares's market cap?

Translational Development Acquisition Corp. Ordinary Shares's market capitalization is USD 210.08M.

What is Translational Development Acquisition Corp. Ordinary Shares's P/E ratio?

Translational Development Acquisition Corp. Ordinary Shares's price-to-earnings (P/E) ratio is 42.9.

What does Translational Development Acquisition Corp. Ordinary Shares do?

Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.